Cargando…
Current updates in machine learning in the prediction of therapeutic outcome of hepatocellular carcinoma: what should we know?
With the development of machine learning (ML) algorithms, a growing number of predictive models have been established for predicting the therapeutic outcome of patients with hepatocellular carcinoma (HCC) after various treatment modalities. By using the different combinations of clinical and radiolo...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936998/ https://www.ncbi.nlm.nih.gov/pubmed/33675433 http://dx.doi.org/10.1186/s13244-021-00977-9 |
_version_ | 1783661300651393024 |
---|---|
author | Zou, Zhi-Min Chang, De-Hua Liu, Hui Xiao, Yu-Dong |
author_facet | Zou, Zhi-Min Chang, De-Hua Liu, Hui Xiao, Yu-Dong |
author_sort | Zou, Zhi-Min |
collection | PubMed |
description | With the development of machine learning (ML) algorithms, a growing number of predictive models have been established for predicting the therapeutic outcome of patients with hepatocellular carcinoma (HCC) after various treatment modalities. By using the different combinations of clinical and radiological variables, ML algorithms can simulate human learning to detect hidden patterns within the data and play a critical role in artificial intelligence techniques. Compared to traditional statistical methods, ML methods have greater predictive effects. ML algorithms are widely applied in nearly all steps of model establishment, such as imaging feature extraction, predictive factor classification, and model development. Therefore, this review presents the literature pertaining to ML algorithms and aims to summarize the strengths and limitations of ML, as well as its potential value in prognostic prediction, after various treatment modalities for HCC. |
format | Online Article Text |
id | pubmed-7936998 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-79369982021-03-21 Current updates in machine learning in the prediction of therapeutic outcome of hepatocellular carcinoma: what should we know? Zou, Zhi-Min Chang, De-Hua Liu, Hui Xiao, Yu-Dong Insights Imaging Critical Review With the development of machine learning (ML) algorithms, a growing number of predictive models have been established for predicting the therapeutic outcome of patients with hepatocellular carcinoma (HCC) after various treatment modalities. By using the different combinations of clinical and radiological variables, ML algorithms can simulate human learning to detect hidden patterns within the data and play a critical role in artificial intelligence techniques. Compared to traditional statistical methods, ML methods have greater predictive effects. ML algorithms are widely applied in nearly all steps of model establishment, such as imaging feature extraction, predictive factor classification, and model development. Therefore, this review presents the literature pertaining to ML algorithms and aims to summarize the strengths and limitations of ML, as well as its potential value in prognostic prediction, after various treatment modalities for HCC. Springer International Publishing 2021-03-06 /pmc/articles/PMC7936998/ /pubmed/33675433 http://dx.doi.org/10.1186/s13244-021-00977-9 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Critical Review Zou, Zhi-Min Chang, De-Hua Liu, Hui Xiao, Yu-Dong Current updates in machine learning in the prediction of therapeutic outcome of hepatocellular carcinoma: what should we know? |
title | Current updates in machine learning in the prediction of therapeutic outcome of hepatocellular carcinoma: what should we know? |
title_full | Current updates in machine learning in the prediction of therapeutic outcome of hepatocellular carcinoma: what should we know? |
title_fullStr | Current updates in machine learning in the prediction of therapeutic outcome of hepatocellular carcinoma: what should we know? |
title_full_unstemmed | Current updates in machine learning in the prediction of therapeutic outcome of hepatocellular carcinoma: what should we know? |
title_short | Current updates in machine learning in the prediction of therapeutic outcome of hepatocellular carcinoma: what should we know? |
title_sort | current updates in machine learning in the prediction of therapeutic outcome of hepatocellular carcinoma: what should we know? |
topic | Critical Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936998/ https://www.ncbi.nlm.nih.gov/pubmed/33675433 http://dx.doi.org/10.1186/s13244-021-00977-9 |
work_keys_str_mv | AT zouzhimin currentupdatesinmachinelearninginthepredictionoftherapeuticoutcomeofhepatocellularcarcinomawhatshouldweknow AT changdehua currentupdatesinmachinelearninginthepredictionoftherapeuticoutcomeofhepatocellularcarcinomawhatshouldweknow AT liuhui currentupdatesinmachinelearninginthepredictionoftherapeuticoutcomeofhepatocellularcarcinomawhatshouldweknow AT xiaoyudong currentupdatesinmachinelearninginthepredictionoftherapeuticoutcomeofhepatocellularcarcinomawhatshouldweknow |